Autres langues ESSA Pharma Inc.

Actions

EPIX

CA29668H7085

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 29/04/2024			Varia. 5j.	Varia. 1 janv.
6,14 ^USD	+0,99 %		-4,06 %	-6,97 %

06/03	Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call
06/03	Le fonds souverain norvégien demande plus de femmes dans les conseils d'administration des entreprises des marchés émergents	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08/03
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	08/03
Norway's wealth fund pushes for more women on emerging market company boards	06/03
ESSA Pharma : Passive Foreign Investment Company Statement	28/02
ESSA Pharma: Fiscal Q1 Earnings Snapshot	13/02
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	13/02
ESSA Pharma Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	13/02
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	26/01
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	25/01
ESSA Pharma: Fiscal Q4 Earnings Snapshot	12/12
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023	12/12
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	12/12
Essa Pharma Insider Bought Shares Worth $133,274, According to a Recent SEC Filing	24/11
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference	21/11
Essa Pharma Insider Bought Shares Worth $419,661, According to a Recent SEC Filing	16/11
ESSA Pharma to Present at the Jefferies London Healthcare Conference	08/11
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	06/11
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	06/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ESSA Pharma Inc.

Actions

EPIX

CA29668H7085

Autres langues

Filtres